BioPorto A/S (CPH: BIOPOR)
Denmark
· Delayed Price · Currency is DKK 1.850
-0.016 (-0.86%)
Sep 25, 2024, 4:59 PM CET
BioPorto Income Statement
Financials in millions DKK. Fiscal year is January - December.
Millions DKK. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '24 Jun 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2014 |
| Revenue | 33.83 | 30.96 | 28.97 | 24.25 | 23.2 | 26.62 | Upgrade
|
| Revenue Growth (YoY) | 13.71% | 6.87% | 19.44% | 4.53% | -12.84% | 2.33% | Upgrade
|
| Cost of Revenue | 9.55 | 10.78 | 9.93 | 9.21 | 9.87 | 9.29 | Upgrade
|
| Gross Profit | 24.28 | 20.18 | 19.04 | 15.04 | 13.34 | 17.33 | Upgrade
|
| Selling, General & Admin | 57.35 | 54.9 | 63.05 | 50.04 | 48.8 | 61.67 | Upgrade
|
| Research & Development | 21.87 | 25.45 | 34.94 | 30.26 | 28.13 | 24.56 | Upgrade
|
| Operating Expenses | 79.21 | 80.35 | 97.99 | 80.3 | 76.93 | 86.23 | Upgrade
|
| Operating Income | -54.93 | -60.16 | -78.94 | -65.26 | -63.59 | -68.9 | Upgrade
|
| Interest Expense | -0.64 | -0.57 | -1.09 | -0.91 | -0.78 | -0.33 | Upgrade
|
| Interest & Investment Income | 1.04 | 1.04 | 0.04 | - | 0 | 0.08 | Upgrade
|
| Currency Exchange Gain (Loss) | -0.43 | -0.43 | 1.14 | 2.46 | -2.4 | 0.43 | Upgrade
|
| Other Non Operating Income (Expenses) | 0.59 | -0.07 | -0.12 | -0.13 | -0.07 | -0.13 | Upgrade
|
| EBT Excluding Unusual Items | -54.38 | -60.2 | -78.96 | -63.84 | -66.83 | -68.85 | Upgrade
|
| Asset Writedown | -1.01 | -1.01 | -2.58 | - | - | - | Upgrade
|
| Other Unusual Items | - | - | - | - | - | -5.4 | Upgrade
|
| Pretax Income | -55.38 | -61.21 | -81.55 | -63.84 | -66.83 | -74.25 | Upgrade
|
| Income Tax Expense | -5.37 | -4.88 | -5.62 | -6.73 | -5.27 | -4.61 | Upgrade
|
| Net Income | -50.02 | -56.33 | -75.92 | -57.11 | -61.56 | -69.64 | Upgrade
|
| Net Income to Common | -50.02 | -56.33 | -75.92 | -57.11 | -61.56 | -69.64 | Upgrade
|
| Shares Outstanding (Basic) | 380 | 358 | 319 | 267 | 205 | 170 | Upgrade
|
| Shares Outstanding (Diluted) | 380 | 358 | 319 | 267 | 205 | 170 | Upgrade
|
| Shares Change (YoY) | 15.17% | 12.54% | 19.12% | 30.21% | 20.53% | 8.78% | Upgrade
|
| EPS (Basic) | -0.13 | -0.16 | -0.24 | -0.21 | -0.30 | -0.41 | Upgrade
|
| EPS (Diluted) | -0.13 | -0.16 | -0.24 | -0.21 | -0.30 | -0.41 | Upgrade
|
| Free Cash Flow | -56.03 | -55.5 | -52.89 | -64.71 | -36.93 | -60.81 | Upgrade
|
| Free Cash Flow Per Share | -0.15 | -0.15 | -0.17 | -0.24 | -0.18 | -0.36 | Upgrade
|
| Gross Margin | 71.76% | 65.19% | 65.73% | 62.01% | 57.49% | 65.09% | Upgrade
|
| Operating Margin | -162.38% | -194.34% | -272.51% | -269.05% | -274.05% | -258.80% | Upgrade
|
| Profit Margin | -147.84% | -181.95% | -262.08% | -235.48% | -265.31% | -261.60% | Upgrade
|
| Free Cash Flow Margin | -165.62% | -179.26% | -182.58% | -266.79% | -159.16% | -228.42% | Upgrade
|
| EBITDA | -54.1 | -59.16 | -77.81 | -64.2 | -62.73 | -68.15 | Upgrade
|
| EBITDA Margin | -159.91% | -191.09% | -268.60% | -264.70% | -270.33% | -255.99% | Upgrade
|
| D&A For EBITDA | 0.84 | 1.01 | 1.13 | 1.05 | 0.86 | 0.75 | Upgrade
|
| EBIT | -54.93 | -60.16 | -78.94 | -65.26 | -63.59 | -68.9 | Upgrade
|
| EBIT Margin | -162.38% | -194.34% | -272.51% | -269.05% | -274.05% | -258.80% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.